ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSTC Globestar Therapeutics Corporation (PK)

0.002
0.0001 (5.26%)
Mar 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 9,838,797
Bid Price 0.002
Ask Price 0.0021
News -
Day High 0.0021

Low
0.00065

52 Week Range

High
0.01

Day Low 0.0018
Share Name Share Symbol Market Stock Type
Globestar Therapeutics Corporation (PK) GSTC OTCMarkets Common Stock
  Price Change Price Change % Share Price Last Trade
0.0001 5.26% 0.002 14:59:07
Open Price Low Price High Price Close Price Previous Close
0.0018 0.0018 0.0021 0.002 0.0019
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
51 9,838,797 US$ 0.001912 US$ 18,810 - 0.00065 - 0.01
Last Trade Type Quantity Price Currency
15:00:51 formt 50,000 US$ 0.0021 USD

Globestar Therapeutics Corporation (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 1.74M 872.27M 446.54M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Globestar Therapeutics (PK) News

Date Time Source News Article
2/15/202410:33Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form..
1/19/202416:13Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
1/02/202415:21Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form..
11/13/202311:32Edgar (US Regulatory)Form 8-K - Current report
8/17/202315:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202315:31Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GSTC Message Board. Create One! See More Posts on GSTC Message Board See More Message Board Posts

Historical GSTC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00140.00210.00120.00171416,535,2500.000642.86%
1 Month0.0010.00210.000650.001177914,346,2120.001100.00%
3 Months0.00120.00210.000650.001119714,995,1080.000866.67%
6 Months0.003050.00430.000650.0013599,922,069-0.00105-34.43%
1 Year0.00930.010.000650.00215546,258,937-0.0073-78.49%
3 Years0.0730.0730.000650.00716964,870,916-0.071-97.26%
5 Years0.0730.0730.000650.00716964,870,916-0.071-97.26%

Globestar Therapeutics (PK) Description

GlobeStar Therapeutics Corporation ("GlobeStar"), headquartered in Richland, Washington, was incorporated in 2016 and owns breakthrough addition of treatment for Multiple Sclerosis and other neurodegenerative diseases as well other pharmaceuticals and nutraceutical. GlobeStar is a clinical stage pharmaceutical company testing a worldwide patented formulation of 3 drugs previously approved by the FDA. Pre-clinical trials in Italy showed the drug combination was effective in the reduction of MS co-morbidities. GlobeStar is initiating discussions with the FDA on clinical trial design in the U.S. in preparation for FDA submission and approval.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com